As attached.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 15.7 pts more than Nifty Microcap 250 and 15.4 pts more than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board approved standalone audited financial results for Q4 and FY ended 31st March 2025. Full-year revenue from operations rose to Rs. 12,559.92 lakhs from Rs. 11,319.14 lakhs (~11% growth), while net profit jumped to Rs. 505.11 lakhs from Rs. 333.79 lakhs (~51% growth). Q4 revenue grew sharply to Rs. 4,318.33 lakhs (vs Rs. 3,098.74 lakhs in Q4 FY24) with Q4 net profit at Rs. 201.75 lakhs. The Board recommended a final dividend of Rs. 0.50 per share (5%) subject to shareholder approval. Mr. Ajay P Patel was appointed as Chief Financial Officer with immediate effect. Auditor G K Choksi & Co. issued an unmodified (clean) opinion on the results.
Strong profit growth (~51% YoY) signals improved operational performance and margin expansion, which is positive for shareholders. The modest 5% dividend and CFO appointment indicate stable governance. Overall, the clean audit report and profit growth are supportive signals for the stock.